Cross Border Licensing Checkmate Capital Group positions itself as a boutique advisor for international licensing and transaction services in biotech, agtech, waste tech and energy tech. This gives sales teams a clear entry point to target firms looking to commercialize technology overseas and enter new markets. Leverage this focus to build outreach lists of mid-market science and tech companies seeking licensing, joint ventures, or strategic partnerships.

Strategic Partnerships The recent MOU with Armstrong Asia demonstrates active cross-border collaboration and a track record in APAC and North American markets. This creates a compelling story for prospective clients who need cross-border deal origination, regulatory navigation, and licensing facilitation between Asia and North America.

Leadership Network The team’s experience at leading firms such as Morgan Stanley, BlackRock, UBS, DFJ Ventures, Panasonic, Samsung, and Milbank LLP signals access to senior decision makers and deep deal experience. Use this to position Checkmate as a trusted partner capable of handling complex transactions and high-stakes negotiations.

Target Client Profile With a lean team and a focus on biotech, medtech, agtech and energy tech developers needing advisory, licensing support, and cross-border deal execution, Checkmate can offer tailored engagement models and quick iteration cycles to attract fast-moving clients.

Tech Driven Advisory The tech stack signals a modern, cloud-based, data-informed approach to market assessments and licensing evaluations. Emphasize capabilities in market due diligence, risk assessment, and licensing feasibility to deliver tangible value to clients pursuing international expansion.